Gw. Hollins et al., RETROPERITONEAL SURGERY - ITS WIDER ROLE IN THE MANAGEMENT OF MALIGNANT TERATOMA, British Journal of Urology, 77(4), 1996, pp. 571-576
Objective To review the results of the use of laparotomy to excise ret
roperitoneal metastases in patients with malignant teratoma of the tes
tis. Patients and methods The results of surgery for retroperitoneal t
eratoma metastases in 37 patients during the 5-year period from 1988 t
o 1993 were reviewed. Information on sexual dysfunction was obtained u
sing a postal questionnaire. Results Patients were divided into three
groups: the first comprised 28 patients who underwent elective surgery
(excision of residual disease) after platinum and bleomycin-based che
motherapy. The second group comprised four patients who underwent inte
rventional surgery to excise disease not responding to treatment, afte
r which they completed chemotherapy. The third group comprised five pa
tients who underwent surgery for relapsed disease; two had suffered an
early and three a late relapse. Overall, 34 patients are alive, four
are considered to have residual disease and two have recently undergon
e re-operation. Conclusions In addition to removing residual disease a
fter primary chemotherapy, surgery has a wider role in the management
of metastatic teratoma. Carefully timed interventional surgery for dis
ease not responding to chemotherapy can be lifesaving. Surgery for ear
ly relapse should be preceded by chemotherapy but surgery alone is app
ropriate where relapse occurs several years after primary treatment, a
lthough raised levels of tumour markers or extensive recurrence might
be an indication for preliminary chemotherapy.